Dashboard
Peptide sales overview
Total Leads
0
Across all stages
Grade A Targets
0
Highest likelihood
Pipeline Value
$0k
Estimated annual
Closed Won
0
Converted leads
Operations Exceptions
8 issues
Margin Analysis by Lot
| Lot / Product | Revenue | COGS | Gross Profit | Margin |
|---|---|---|---|---|
Semaglutide 5mg VL-2026-002 | $7.2k | $4.3k | +$2.9k | 40.6% |
CJC-1295/Ipamorelin 5mg BR-2026-001 | $950 | $571 | +$379 | 39.9% |
BPC-157 5mg VL-2026-001 | $705 | $372 | +$333 | 47.2% |
Pipeline Overview
Recent Leads
View allNo leads yet. Generate leads with AI, import from Apollo, or load sample data to explore.
Recent Activity
Latest lead updates and notes
No activity yet.